Cargando…
A Single Dose of the Deactivated Rabies-Virus Vectored COVID-19 Vaccine, CORAVAX, Is Highly Efficacious and Alleviates Lung Inflammation in the Hamster Model
Without sufficient herd immunity through either vaccination or natural infection, the coronavirus disease 2019 pandemic is unlikely to be controlled. Waning immunity with the currently approved vaccines suggests the need to evaluate vaccines causing the induction of long-term responses. Here, we rep...
Autores principales: | Kurup, Drishya, Wirblich, Christoph, Zabihi Diba, Leila, Lambert, Rachael, Watson, Megan, Shaikh, Noor, Ramage, Holly, Solomides, Charalambos, Schnell, Matthias J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9229041/ https://www.ncbi.nlm.nih.gov/pubmed/35746597 http://dx.doi.org/10.3390/v14061126 |
Ejemplares similares
-
Rabies virus-based COVID-19 vaccine CORAVAX™ induces high levels of neutralizing antibodies against SARS-CoV-2
por: Kurup, Drishya, et al.
Publicado: (2020) -
Inactivated rabies virus vectored SARS-CoV-2 vaccine prevents disease in a Syrian hamster model
por: Kurup, Drishya, et al.
Publicado: (2021) -
Measles-based Zika vaccine induces long-term immunity and requires NS1 antibodies to protect the female reproductive tract
por: Kurup, Drishya, et al.
Publicado: (2022) -
Effects of adjuvants in a rabies-vectored Ebola virus vaccine on protection from surrogate challenge
por: Yankowski, Catherine, et al.
Publicado: (2023) -
Inactivated rabies-vectored SARS-CoV-2 vaccine provides long-term immune response unaffected by vector immunity
por: Yankowski, Catherine, et al.
Publicado: (2022)